Equity research of novo Nordisk - a shift in focus: from insulin to GLP-1

This equity research has the purpose of projecting Novo Nordisk’s operations within the next5 years. There is a growing trend in the company’s focus towards the GLP-1 segment, shifting away from the traditional focus on in sulinglargine. In addition, there is a perception that insulin industry compe...

ver descrição completa

Detalhes bibliográficos
Autor principal: Cavalcanti, Eduardo Burguet (author)
Formato: masterThesis
Idioma:eng
Publicado em: 2022
Assuntos:
Valuation
Forecasting
Health
Finance
Equity research
Health care
Insulin
Pharmaceutical industry
Patents
Glp-1
Obesity
Pipeline
Pharmaceuticals
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
Texto completo:http://hdl.handle.net/10362/144714
País:Portugal
Oai:oai:run.unl.pt:10362/144714

Texto Completo

http://hdl.handle.net/10362/144714

Registros relacionados